| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.39 | 0.02 |